Dr. Hakim Benamer††
Interventional cardiologist, Foch Hospital, Suresnes and Hôpital Européen de Paris – GVM Care & Research, Aubervilliers, France
At a glance
Intraprocedural 3D stent reconstruction
With 3DStent*, leveraging C-arm motion compensated computed tomography (CMCT) imaging, we are introducing an intraprocedural tool for 3D visualization of the coronary stent.
Remove major stent imaging barriers
Three-dimensional stent imaging with zero additional contrast media, zero additional devices and zero additional procedural costs.
Easy image interpretation and fast measurements
Intuitive images and straightforward user interface for fast stent-diameter and stent expansion measurements.
Available on Allia™ systems†, our innovative intraprocedural 3D stent reconstruction technology leverages CMCT imaging. 3DStent is designed to remove major stent imaging barriers and provide easy to interpret images leveraging CMCT imaging.
At GE HealthCare, our goal is to collaborate with healthcare professionals and interventional cardiologists to deliver superior care. Over the past 25 years, we have introduced life-changing technologies such as the first flat-panel with Innova 2000, comprehensive solutions to plan, guide, and assess your procedures with ASSIST, and the first AI-based image chain for automatic dose adjustments with AutoRight™.
With 3DStent, we are going one step further by introducing a tool allowing you to visualize a coronary stent in 3D during the procedure. Leveraging CMCT technology, see your stent from all angles without inserting any additional devices.
“3DStent acquisition is simple and doesn’t require any additional contrast media injection.”
Dr. Hakim Benamer††
Interventional cardiologist, Foch Hospital, Suresnes and Hôpital Européen de Paris – GVM Care & Research, Aubervilliers, France
“For the first time we have a detailed depiction of the stent during the procedure without the use of intracoronary imaging... it literally takes 10 seconds to understand what we are seeing.”
Dr. Carlos Collet††
Interventional cardiologist. CV Center Aalst, Belgium
Stent underexpansion has been identified as a strong predictor of major adverse outcomes defined as cardiac death, target lesion related myocardial infarction, or stent thrombosis. Clinical studies show that achieving stent expansion with a minimal stent area (MSA) greater than 5.0 mm², measured with IVUS, was associated with significantly improved long-term clinical outcomes compared to both underexpansion and angiography alone.
With 3DStent, leveraging CMCT imaging, we are introducing an intraprocedural tool for 3D visualization of the coronary stent.
The image is acquired through an automated rotation of the C-arm, providing both 3D and multi-slice images.
Today, you can use different imaging modalities such as intravascular imaging and stent enhancement. However, despite their demonstrated benefit, adoption remains limited.
3DStent is a complementary tool, providing you with essential 3D information with zero additional contrast media, zero additional devices and zero additional procedural costs.
In imaging, it is sometimes challenging to understand and analyze the different elements shown on the screen. 3DStent images are intuitive and easy to understand. Simple images lower the learning curve and allow for faster image interpretation.
In a couple of clicks, get all the information you want like length, diameter and cross-sectional areas.
Thanks to 3DStent, assess stent expansion confidently: stent area measurements with 3DStent highly correlate with IVUS measurements2.
* 3DStent solution includes Allia system, 3DXR and Volume Viewer Innova, and requires AW workstation with Volume Viewer. These applications are sold separately. Not available for sale in all countries.
† Available on Allia IGS 5 with 20-cm or 30-cm detector and Allia IGS 7 with 30-cm detector.
†† Dr. Benamer and Dr. Collet are paid consultants for GE HealthCare. The statements described here are based on their own opinions related to offline image reviews from a product prototype.
1. Lee YJ, et al. Impact of intravascular ultrasound–guided optimal stent expansion on 3-year hard clinical outcomes. Circ Cardiovasc Interv. 2021;14:e011124. DOI: 10.1161/CIRCINTERVENTIONS.121.011124
2. Ruiz, et al. Rotational angiography accurately predicts minimal stent area – a comparison with IVUS. Journal of the Society for Cardiovascular Angiography and Interventions, May 2025, DOI:10.1016/j.jscai.2025.102723.